Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma

Published:2014-01-31 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Haj Mohammad Nadia,Hulshof Maarten CCM,Bergman Jacques JGHM,Geijsen Debby,Wilmink Johanna W,van Berge Henegouwen Mark I,van Laarhoven Hanneke WM

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-56.pdf

Reference17 articles.

1. Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010, 46: 765-781. 10.1016/j.ejca.2009.12.014.

2. Gebski V, Burmeister B, Smithers BM, et al: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007, 8: 226-234. 10.1016/S1470-2045(07)70039-6.

3. van Hagen P, Hulshof MC, van Lanschot JJ, et al: Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012, 366: 2074-2084. 10.1056/NEJMoa1112088.

4. Chak A, Canto M, Gerdes H, et al: Prognosis of esophageal cancers preoperatively staged to be locally invasive (T4) by endoscopic ultrasound (EUS): a multicenter retrospective cohort study. Gastrointest Endosc. 1995, 42: 501-506. 10.1016/S0016-5107(95)70001-3.

5. Fockens P, Kisman K, Merkus MP, et al: The prognosis of esophageal carcinoma staged irresectable (T4) by endosonography. J Am Coll Surg. 1998, 186: 17-23. 10.1016/S1072-7515(97)00131-2.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?;Siberian journal of oncology;2024-05-10

2. Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis;International Journal of Radiation Oncology*Biology*Physics;2023-09

3. What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?;International Journal of Molecular Sciences;2022-10-30

4. Activity Monitoring for Toxicity Detection and Management in Patients Undergoing Chemoradiation for Gastrointestinal Malignancies;JCO Oncology Practice;2022-06

5. Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer;JAMA Network Open;2022-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3